PREVENTION AND TREATMENT OF HCV INFECTION EMPLOYING ANTIBODIES DIRECTED AGAINST CONFORMATIONAL EPITOPES

Details for Australian Patent Application No. 2002246545 (hide)

Owner BOARD OF TRUSTEES OF LELAND STANFORD JUNIOR UNIVERSITY

Inventors FOUNG, Steven, K., H.; HADLOCK, Kenneth, G.; KECK, Zhen-yong

Pub. Number AU-A-2002246545

PCT Pub. Number WO2002/057314

Priority 09/728,720 01.12.00 US

Filing date 30 November 2001

Wipo publication date 30 July 2002

International Classifications

C07K 016/00 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

13 February 2003 Application Open to Public Inspection

  Published as AU-A-2002246545

5 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002246546

2002246544-ANTIMICROBIAL QUINOLONE DERIVATIVES AND USE OF THE SAME TO TREAT BACTERIAL INFECTIONS